what are the 4 main classes of biomolecules,nucleic acids<br>proteins<br>carbohydrates<br>lipids,0,,
what are some functions of nucleic acids,"information, catalysis",0,,
what are some functions of proteins,"catalysis (enzymes), structure, signalling (eg spike protein on SARS-COV-2)",0,,
what are some functions of carbohydrates,"energy, structure, signalling",0,,
what are some functions of lipids?,"encapsulation (lipid layer/bilayer), signalling",0,,
nucleic acids are made from,nucleotides,0,,
proteins are made from,amino acids,0,,
carbohydrates are made from,monosaccharides,0,,
DNA/RNA are polymers of,nucleotides,0,,
polypeptides are polymers of,amino acids,0,,
what is the difference between the sugars in DNA and RNA,"the sugar in DNA is missing a hydroxyl group at the 2' position (ie the sugar is 2'-deoxy-D-ribose)<br><img src=""paste-b62a98bee0b2baf96153eff75f023eec12fb5f25.jpg"">",0,,
what is the difference between a nucleo<u>tide</u>&nbsp;and a nucleo<u>side</u>,"nucleotide contains phosphate, whereas nucleoside is just the base + sugar",0,,
why are phosphate (phosphodiester) linkages strong and thus used in connecting nucleotides,kinetically stable AND thermodynamically higher energy than its breakdown products,0,,
how are VGICs named,"<img src=""paste-faf7f60b314e79ab0c9ced16f5da49a4c10c12e4.jpg"">",0,,
describe the structure of Na and Ca VGICs,"4 membered domain with each member consisting of 6 subunits (S1-S6). S1-S4 consist of the voltage-sensing region, whereas S5 and S6 and their pore loop are responsible for ion conduction and conmprise the gate and pore of the channel.<br>Na VGICs have an accessory&nbsp;β2/4 accessory subunit at the N terminus and a β1/3 accessory subunit at the C terminus<br>Ca VGICs have an accessory 𝛾 accessory subunit at the N terminus consisting of 4 subunits and an ⍺2∂ subunit at the C terminus<br><img src=""paste-bffaaeebbed1e50674093b8090347d37385bb379.jpg""><img src=""paste-cc73a674a6eed6c1e3f626f4ba39ebda81d1d7e3.jpg"">",0,,
what are TRP channels,TRP = transient receptor potential<br>often non-selective and can be activated by diff molecules,0,,
describe the structure of TRP and K VGICs,"4 membered domain w/ each member consisting of six subunits. However, different to Na and Ca channels, all four members are identical.",0,,
what are some functions of&nbsp;β subunits of VGICs,"- regulate expression levels, location &amp; trafficking(where in membrane channel is expressed)<br>- alter voltage dependence of activation or inactivation<br>- can mind drugs that modulate function",0,,
describe the structure of the pore and channel of VGICs,"3Å wide ""selectivity filter"" lined w/ amino acid residues, determining what ion can/cannot pass through. then followed by a 10Å wide aqueous channel where the ion can pass through into the cell<br><img src=""paste-78ef7891962a14782a9ed4583e6ceec9c055c794.jpg"">",0,,
how do VGICs open,"- open in response to change in membrane potential (change in concentration of ions on each side of membrane)<br>- VGICs contain a voltage sensor (S1-S4) which moves in response to change in membrane potential<br><img src=""paste-546c035ce0a671c0fdf5ae7e0cee0d2307cd8a43.jpg"">",0,,
what is the difference between deactivation and inactivation of a VGIC,<b>deactivation:&nbsp;</b>when the membrane potential returns to its resting state and the channel may close<br><br><b>inactivation:&nbsp;</b>the channel closes even when still depolarised. influx of +ve charge causes an intracellular domain to swing into open pore to block ion flow,0,,
what are some examples of drugs that modulate Na<sub>v</sub> activity,tetrodotoxins<br>phenytoin and carbamazapine<br>local anesthetics,0,,
how do tetrodotoxins modulate Na<sub>v</sub> activity,binds to the external surface of the ⍺ subunit of the channel in the S5-S6 loop region to block pore<br>used mainly as experimental tools to block Na<sub>v</sub> channels in vitro,0,,
how do phenytoin and carbamazapine modulate Na<sub>v</sub>&nbsp;activity,slows recovery from inactived state (thus limits firing rate of neurons)<br>used in treatment of epilepsy,0,,
how do local anesthetics modulate Na<sub>v</sub>&nbsp;activity,"binds to channel at sites exposed to lipid membrane, which blocks the channel",0,,
what are some intracellular processes that entry of Ca<sup>2+</sup> causes,- muscle contraction<br>- neurotransmitter release<br>- activation of 2nd messenger systems (GPCRs?)<br>- alteration in gene expression<br>- apoptosis<br>- depolarization,0,,
what is membrane depolarisation,a process that shifts the electrical charge distribution so that the cell is less negatively charged compared to the environment<br>ie intracellular is more +vely charged than extracellular,0,,
how do gabapentin and pregabalin modulate Ca<sub>v</sub> channels,they bind to the ⍺2δ subunit to disrupt trafficking of the channel to the membrane<br>they're selective for Ca<sub>v</sub>2.2 (N-type) channels that regulate neurotransmitter release in sensory neurones,0,,
what are the two main TRP channels involved in pain perception,TRPV1 and TRPA1,0,,
what happens when TRPA1 and TRPV1 channels are activated,"<img src=""paste-ba63d1c5ab3065da475df8a0c3ec2c54689ad0c5.jpg"">",0,,
on which synaptic neuron(s) are GPCRs located?,both pre and post synaptic,0,,
describe the general structure of the membrane-bound portion of a GPCR (ie the part they all have in common),7 transmembrane domain<br>each domain is an anti-clockwise ⍺ helix comprising of ~25-35 amino acids with a relatively high degree of hydrophobicity,0,,
whatr type of extracellular domain do glutamate/class C GPCRs have and what does it do,"venus fly trap domain for binding ligand<br><img src=""paste-1ab5a36d3be66892ab396b4c9d5848bbd5388777.jpg"">",0,,
where is the binding pocket within rhodopsin/class A GPCRs,"deep within extracellular mouth<br><img src=""paste-3f4cbaa57d84d50b0ca14fa01fabeb6da7afb8e3.jpg"">",0,,
how does a GPCR move from its inactive to active state?,"conformational switch of 7TM domain (ie ⍺ helices move), mainly TM6 which moves",0,,
what effect does activation of a GPCR have on the g-protein,"movement of TM6 slightly dislodges ⍺ subunit of g-protein, which triggers conversion GDP (inactive) --&gt; GTP (active), which is then released from ⍺ subunit",0,,
what are the 3 subtypes of the ⍺ subunit and what does their subscript mean?,G<sub>s</sub> = stimulatory<br>G<sub>i/o</sub> = inhibitory<br>G<sub>q</sub> = quirky,0,,
what happens when a GPCR becomes activated that has a G<sub>s</sub> subtype G-protein,GDP --&gt; GTP<br>GTP then binds to adenylyl cyclase which makes ATP --&gt; cAMP<br>cAMP then binds to protein kinase A which then performs many functions,0,,
"what happens when a GPCR becomes activated that has a G<span style=""font-size: 16.6667px;"">i</span>&nbsp;subtype G-protein","Gi subunit also on adenylyl cyclase (AC), so GTP from Gi protein of GPCR unable to bind to AC and make ATP --&gt; cAMP thus leaving protein kinase A inactivated&nbsp;",0,,
what does protein kinase A (PKA) do/do to neuronal activity?,can phosphorylate and alter activity of signalling proteins<br>can enter nucleus and alter transcruption of important synaptic proteins<br>presynaptically: ⇑ neurotransmitter release thru action on vesicle release machine<br>postsynaptically: can phosphorylate transcription factors &amp; upregulate transcription of important synaptic proteins,0,,
how is the Gq subunit different to Gs and Gi,"Gq has no effect on AC (ie does not produce any cAMP). through a series of rxns its activation releases Ca2+ from intracellular stores<br><img src=""paste-d6d2ff9735f7e4488604e70ead9d95a7e4832fdb.jpg"">",0,,
"what are some types of Gs, Gi, and Gq subunits","Gs: D1R, β1R<br>Gi: D2R, ⍺2AR<br>Gq: M1R, ⍺1AR",0,,
what happens when a GPCR with Gq subtype G protein is stimulated,GTP released by Gq stimulates phospholipase-C then protein kinase-C and mobilises calcium,0,,
how does nature add a new nucleotide to a growing chain,"<img src=""paste-0d50f8cf0d004d6dcd3351673e158e4a084d1f72.jpg"">",0,,
what is a phosphoramidite and why is it used for synthetic DNA synthesis,"phosphoramidite = P bonded to two O and one N<br>P centre is in lower oxidation state and there is less -vely charged oxygens (like in phosphate) thus is is a better nucleophile<br><img src=""paste-7466983092dbaf184ece1e3bf146ea4f283f2698.jpg"">",0,,
what is chemoselectivity,controlling which functional group will react when there is &gt;1 that can,0,,
what are protecting groups and why are they important,protecting groups are often bulky substituents that can 'hide' or 'protect' functional groups from reacting<br>important for controlling chemoselectivity<br>e.g. DMT which is always attached to 5' oxygen,0,,
the amine of a phosphoramidite is not a good leaving group. how is this barrier overcome?,"use of a catalyst tetrazole<br><img src=""paste-c3388336f8cefd5a459a6fbb4b876d1b365d3165.jpg""><br>nitrogen within tetrazole then attacks H of 5' hydroxyl of next nucleoside. deprotonated 5' oxygen then attacks P and protonated tetrazole leaves.<br><img src=""paste-5204080eb09e71233d63943357573d9bbaa88bec.jpg"">",0,,
how is the phosphite P<sup>III</sup> turned into phosphate P<sup>V</sup> after tetrazole leaves during syntyhetic DNA synthesis,"oxidation by a base (2,6-lutidine) in the presence of aqueous iodine I<sub>2&nbsp;</sub>",0,,
how are the remaining protecting groups cleavedin synthetic DNA synthesis and when is this step performed,cleaved with ammonia (expcept for DMT which is cleaved with trichloroacetic acid)<br>happens after all nucleosides have been connected as it also cleaves the oligo from the glass bead at the last 3' oxygen,0,,
what is the driving force in helix formation,hydrophobic effect - nucleobases are mostly hydrophobic so it is more entropically favourable to bury them inside together and have the hydrophilic phosphate facing outwards,0,,
what are intercalators,"molecules which are able to insert themselves into a DNA strand and stack between base pairs (π-π sracki<br>normally polycyclic, lots of aromaticity, have&nbsp; 4º amine to interact w phosphate<br>eg&nbsp;<img src=""paste-77705180c9623f6e86efc5e5f1878542eca132ae.jpg"">",0,,
what are DNA alkylators/crosslinkers,good electrophiles which can interact w DNA,0,,
what is the isoelectric point (pI) of an amino acid &amp; how is it calculated,"the pH at which an amino acid is in all its zwitterionic form (ie overall net neutral charge)<br>the average of two pKa values<br><img src=""paste-c2697640e158113473577c21c7587d2b49455458.jpg"">",0,,
why are amide bonds the bond used in peptides?,"amides are v stable to hydrolysis<br>overlap between N lone pair and C=O π* orbital makes carbonyl group less reactive<br><img src=""paste-02edacb66f0f6f54818e3c77d9fe3c2e0028509b.jpg"">",0,,
under which conditions is Fmoc removed?,basic conditions&nbsp;<br>ie it is 'base-labile',0,,
under which conditions is Boc removed?,acidic conditions<br>ie it is 'acid-labile',0,,
"draw the mechanism for how Fmoc is added to a peptide vis Fmoc-Cl mechanism<br><img alt=""Fmoc chloride"" src=""https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/structures/330/813/2aca43d8-66c4-46a1-8686-fc2b75853398/640/2aca43d8-66c4-46a1-8686-fc2b75853398.png"">","<img src=""paste-2255a82a3f50cf89579664a490122559c64156c1.jpg"">",0,,
"draw the mechanism for how Boc is added to a peptide (via Boc anhydride)<br><img alt=""Di-tert-butyl pyrocarbonate - Optional[FTIR] - Spectrum - SpectraBase"" src=""structure.png"">","<img src=""paste-2f40a028b05f7b731e925cfc99f8ba77dbd650de.jpg""><br>CO2 bubbles off",0,,
draw the mechanism for Fmoc deprotection in basic conditions (base is piperidine),"<img src=""paste-b8ac2cee36f18bbfb7f3f1359e09fab27eca7fc2.jpg"">",0,,
draw the mechanism for how Boc is removed w acid,"<img src=""paste-113621908d4ee1dd7c22a49171475fb4701197bd.jpg"">",0,,
side chains are procted with ____-labile groups,acid,0,,
what type of protecting group is used on the COO- of a peptide and why are they used?,"DCC/HOtBt<br>used because they&nbsp;<b>activate</b>&nbsp;the carbonyl to make it more reactive as an electrophile. DCC contains a carbodiimide<br>x<img src=""paste-b4c822e7943119b9b38d9b559dacbaf7d1eaf744.jpg"">&nbsp;<img src=""paste-9dc554f537f0fc9ae2b2829c239c3219a35d30b5.jpg"">",0,,
draw the mechanism for addition and removal of DCC to an amino acid (use glycine being added to lysine),"<img src=""paste-7a848cfff555bd260606268bdbe4fe277a1fdc1f.jpg"">",0,,
why is HOBt a better activating group than DCC?,"less prone to epimerisation (intramolecular scrambling at stereocentre)<br><img src=""paste-5692046cdbfc7a8afadb21c40ac7320b97ada596.jpg"">",0,,
how does nature couple amino acids?,"all occurs at ribosome<br><img src=""paste-d1b0847e02e7fef857773a8fcc4ed909463691cd.jpg"">&nbsp;&nbsp;<img src=""paste-d1dfd234379bd60894e493ae62a3ac82a05eb5b4.jpg"">",0,,
why are amide bonds used in nature/so strong?,resistant to hydrolysis<br>C-N has partial double bond character due to resonance,0,,
what makes an amino acid have the 'L' con figuration,"H2N is on the left hand side in a fischer projection<br><img src=""paste-cf9020db078d06bd92c6903c1b76b3f5df92d89c.jpg"">",0,,
what is the hydrophobic effect and why does it occur,non-polar/aliphatic/<b>hydrophobic</b>&nbsp;residues bury themselves within the protein so they do not come in contact w/ water. this is entropically favourable as it frees water molcules instead of water having to orient itself around these residues.,0,,
what are disulfide bonds,"covalent bonds that form between two thiol residues (cysteine or methionine)<br>can be intra or inter chain linkages<br><img src=""paste-34b63cc4f66ab5ee6563b4d93fb008a9c898515a.jpg"">",0,,
what are six general classes of enzymes and what do they do?,1. oxidoreductases (redox rxns)<br>2. transferases (transfer of molecules)<br>3. hydrolyases (hydrolysis)<br>4. lysases (other cleavage rxns)<br>5. isomerases (isomerisation of chiral centres)<br>6. ligases (addition of a group),0,,
what are proteases,enzymes that hydrolyse peptide bonds,0,,
what is the difference between a serine protease and cysteine protease,a serine protease has a serine residue in its catalytic active site<br>a cysteine protease has a cysteine residue in its catalytic active site<br>,0,,
what is the difference between an endo- and exo-protease,exo-proteases cleaves peptide bonds from the end of a polypeptide chain<br>endo-proteases cleave peptide bonds in a specific place in the middle of a chain,0,,
draw the mechanism of peptide cleavage by a serine protease,"<img src=""paste-ac9bc09e4b3490a6e4743412926c54c3d1124d09.jpg""><br><img src=""paste-4ff14a0fd8ec6c7df2ab23303dac9fec67b5d230.jpg""><br><img src=""paste-8ff47ebd2342482cefacafe6ad32e15547dfd716.jpg""><br><img src=""paste-c279f7689259392a0e425f8ffdbf6c83d4194234.jpg""><br><img src=""paste-2b9693c7749d3150ab3b6848eb25d98beb247075.jpg"">",0,,
what are some techniques used in determining the tertiary sturcture of a protein,NMR spectroscopy<br>X-ray crystallography<br>Cryo-electron microscopy,0,,
what are cofactors,biological reagents involved in enzyme catalysis,0,,
"what is NADH/NAD+/NADPH, what does it do and which part of the molecule reacts?","nicotinamide adenine dinucleotide<br>source of hydride H- (reduces carbonyl groups in vivo)<br><img src=""paste-df64d4060e0348531fc5742979f5135fe7599910.jpg"">",0,,
"what is FAD, what function does it serve, and which part of the molecule reacts?","Flavin adenine dinucleotide<br>Redox coupling (FAD = H- acceptor, FADH2 = H- donator)<br><img src=""paste-29e8a5759c59af62ad408c609dd731f1d39e8d4d.jpg"">opposite nitrogens react",0,,
"what is SAM, what function does it serve, and which part of the molecule reacts?","S-adenosyl methionine<br>Methylating agent<br>methyl substituent on sulfonium linkage gets removed by a nucleophile<br><img src=""paste-15d5fd1ecef975ba7525a13b433296228f703142.jpg"">",0,,
what function does pyridoxal phosphate serve and which part of the molecule reacts?,"Activates amino acids<br>N of amino acid will attack aldehyde to form an imine which can then act as a nucleophile<br><img src=""paste-77208f583786cb9d93df5cc2d215d67275455547.jpg"">",0,,
"what is CoA/AcCoA, what function does it serve and which part of the molecule reacts?","Acetyl Coenzyme A transfers acetyl groups and so on (eg can also transfer malonyl groups and so on...)<br>Large molecular crane with terminal thiol --&gt; thiol is the real workhorse of the molecule<br><img src=""paste-dbac8e77804d2c371790929bf1e277260fc005e4.jpg"">",0,,
why and thus how do thioesters react differently to esters?,"orbital overlap in a thioester is poor, 3p of S and 2p of carbon do not overlap well<br>THUS - hydrolysis and enolisation of thioesters is much easier",0,, 
what is one major function of acetyl CoA?,build up fatty acids,0,,
how are L/D configuartions assigned?,"in a fischer projection...<br>- focus on penultimate carbon (ie last stereogenic centre)<br>- if high priority group if RHS, then it is D<br>- if high priority group is LHS, then it is L<br><img src=""paste-eda31fe795dea83c803fd288a2ea89fcc67c3023.jpg"">",0,,
where are the aldehyde/ketone and -CH2OH positioned in a fischer projection?,aldehyde/ketone on top<br>CH2OH on bottom,0,,
L and D glucose are _____ of one another,enantiomers,0,,
what are epimers?,"changing the configuration at just one of the stereogenic carbons in a sugar<br>e.g. Mannose is the C2 epimer of glucose<br><img src=""paste-649180b13dcd1cfe6892a9386113ae10dcb1e0a3.jpg"">",0,,
draw the general mechanism for the acid catalysed cyclisation of glucose,"<img src=""paste-4a2970f3424a9732b9cf1b5e450a6226768b7c3f.jpg"">",0,,
what is the difference between β-glucose and ⍺-glucose,"β-glucose has -OH of hemi-acetal pointing&nbsp;<b>up&nbsp;</b>(above ring, adjacent w 1º alcohol)<br>⍺-glucose has -OH of hemi-acetal pointing&nbsp;<b>down</b>&nbsp;(below ring)<br><img src=""paste-f8429cd42911d99a896f823f78914dc099a7adb6.jpg"">",0,,
β-glucose and ⍺-glucose are known as _____,anomers<br>and the hemiacetal centre is the anomeric centre,0,,
what is the conversion between two anomers known as?,mutarotation,0,,
what is the anomeric effects?,"<img src=""paste-6d4fd91454d2db56e1c4dcef86c7866e5e1dfc2c.jpg""><br>tetrahydropyran = 6 membered ring w/ an oxygen<br>axial = pointing down. opposite is equitorial, which are facing out of ring (on same plane as ring)<br>this means that the ⍺ anomer of glucose is favoured",0,,
why is ⍺-glucose more present in solution than β-glucose,"the axial conformation allows a favourable orbital interaction<br><img src=""paste-867e88c570d6012ccd6feeab27caa0417d6fd1cf.jpg"">",0,,
what are the general names for a 5 and 6 membered ring form of a sugar?,"6 = pyranose<br>5 = furanose<br>name comes from:<br><img src=""paste-21be1fbcbe203f77a98c2e09ced9e466ed2fa869.jpg"">",0,,
"if you reduce the C1 carbon of glucose, what product do you attain? draw and name the product&nbsp;","product is an alditol.<br><img src=""paste-43adc648625448f3aef034302bc8a161e1c8d8f8.jpg"">",0,,
what happens if you oxidise the C1 carbon of glucose? draw and name the product,"product is gluconic aicd (general name is aldonic acid)<br><img src=""paste-1ae425dad856f993c5da14e2267e0f718e3c7664.jpg"">",0,,
what happens if you oxidise the C6 of glucose? name and draw the product and identify the enzyme that catalyses this reaction,"product is glucuronic acid (general name is uronic acid)<br><img src=""paste-1e28a5c6091a1473d55bb3e5ceef297083d4cf9c.jpg""><br>enzyme = glucose oxidase",0,,
what happens when the hemiacetal of glucose reacts with alcohol? draw the mechanism and name the product&nbsp;,"product is an glycoside (an acetal). H+ catalysed<br><img src=""paste-cf07cc7a531eea510d6d93c24bc3c2308d8f602b.jpg""><br>new bond is called a GLYCOSIDIC BOND<br><img src=""paste-66c0f26e5df013869c6e895db9f5e15fd33f5733.jpg"">",0,,
how are linkages between two sugars named?,"start w/ LHS sugar, is it ⍺ or β?&nbsp;<br>linkage always starts from C1 on LHS sugar.<br>which carbon is the oxygen making a bond on the RHS sugar?&nbsp;<br>e.g. if C4 and the LHS carbon is β, the linkage is β(1--&gt;4)<br>e.g. lactose<br><img src=""paste-d83012512062012d692de86d9e722d2eb49aa590.jpg"">",0,,
what are amino sugars?,sugars in which one -OH is replaced by an amine,0,,
what are the 5 monoamine neurotransmitters and what are the two classes?,<b>catacholamines:<br>-&nbsp;</b>dopamine<br>- norepinephrine<br>-epinephrine<br><b>indoleamines:</b><br>- serotonin (5-HT)<br>- melatonin,0,,
describe the synthesis of the catecholamine neurotransmitters,"1. Tyrosine hydroxylase adds -OH substituent to L-tyrosine to form L-DOPA<br>2. L-aromatic acid decarboxylase removes -COOH of L-DOPA to form dopamine (dopaminergic neurons stop synthesising here)<br>3. Dopamine β hydroxylase adds -OH to β carbon from NH2 to form norepinephrine (noradrenergic neurons stop synthesising here)<br>4. PNMT adds methyl substituent to NH2 of NE to form epinephrine<br><img src=""paste-cfcaa54865568d783d821b6f80bc31ce0400f015.jpg"">",0,,
describe 5-HT synthesis,"1. Tryptophan hydroxylase adds -OH substituent to indole ring (C opposite that C in benzene ring bonded to N is, '5' position?)<br>2. L-aromatic acid decarboxylase removes -COOH to form 5-HT",0,,
"describe ""traditional"" synaptic release",1. terminal depolarisation<br>2. Ca2+ channel opens and Ca2+ influxes<br>3. Ca2+ entry promotes fusion of vesicles to the membrane<br>4. exocytosis of monoamine NT into synapse,0,,
where are 5-HT and NA also released from?,"also released from varicosities (""buds"" that come off axons)<br><img src=""paste-24df2fa143d2096214518848ce2c8f3cf580218c.jpg"">",0,,
what are some drugs that target monoamine synthesis?,"-L-DOPA (can be given as a drug, ⇑DA)<br>- dietary tryptophan (⇑ 5-HT)<br>- MDMA (inhibits tryptophan hydroxylase, ⇓ 5-HT)",0,,
what are some drugs that target storage and release of monoamines?,"- amphetamines (disrupt storage, ⇑ DA)<br>- Resperine (disrupts stoage of NA in vesicular transporter storage)",0,,
where is NA synthesised?,locus coeruleus,0,,
where is 5-HT synthesised,raphe nuclei,0,,
where is dopamine synthesised?,ventral tegmental area<br>substantia nigra,0,,
how are monoamines reuptaked from the synapse?,"active transport via high affinity Na+ dependent membrane transport protein<br>DAT, NAT, SERT",0,,
what are some drugs that target monoamine transport,"- cocaine (block DAT, ⇑DA)<br>- amitriptyline (block NAT and SERT)",0,,
how are monoamines degraded?,"in neurons by oxidative deamination by monoamine oxidase (MAO)<br>MAO isoforms:<br>- MAO-A (degrades 5-HT, NA, Adr, DA)<br>- MAO-D (degrades DA)<br>catechol-O-methyl transferase (COMT) also involved, usually on extraneuronal locations",0,,
describe how DA is degraded,"2 pathways:<br>1) COMT degrades DA to 3-MT, then MAO converts 3-MT to homovanillic acid (HVA)<br>2) MAO converts DA to DOPAC, then COMT coverts DOPAC to HVA",0,,
describe NA degradation,"2 pathways:<br>1) COMT coverts to normatadrenaline, then MAO-A converts to MOPGAL, then Aldehyde dehydrogenase forms <span style=""background-color: rgb(170, 0, 127);""><b>vanillylmandelic acid (VMA)</b></span><br>2) MAO-A converts to DOPGAL, then Aldehyde dehydrogenase converts DOPGAL to DOMA, then COMT converts DOMA to VMA",0,,
describe 5-HT degradation,"1. MAO converts to 5-hydroxyindole acetalaldehyde<br>2. Aldehyde dehydrogenase then converts into 5-hydroxyindole acetic acid <b><span style=""background-color: rgb(170, 0, 127);"">(5-HIAA)<br></span></b><img src=""paste-9d6b894778cb97d7b8fb435ba61d33c2251ac600.jpg""><b><span style=""background-color: rgb(170, 0, 127);""><br></span></b>",0,,
what are some drugs that target monoamine degradation,"- moclobemide (inhibits MAO-A, ⇑[monoamine])",0,,
identify drug targets within the monoamine system,- synthesis<br>- storage &amp; release<br>- receptors<br>- uptake<br>- degradation,0,,
what is the main difference between small molecule NTs and neuropeptides?,"amino acid NTs --&gt; mainly fast receptors (excitation)<br>monoamine NTs --&gt; mainly slow receptors (modulatory)<br>neuropeptides --&gt; mainly slow receptors (modulatory), most are only active locally",0,,
what is a neuropeptide? &amp; what are some examples,"""a small protein or polypeptide which acts as a neurotransmitter in the nervous system""<br>some neuropeptides also act as hormones (eg oxytocin)",0,,
describe the synthesis of neuropeptides,"neuropeptide synthesis:<br>- requires transcription and translation<br>- cleavage of N terminus creates propeptide (like a prodrug - can become something useful)<br>- propeptide packed into dense vesicles and <span style=""background-color: rgb(170, 0, 127);"">undergoes post-translational modifications to become neuropeptide</span>",0,,
what are the key differences between small molecule NT and neuropeptide synthesis?,#NAME?,0,,
describe the storage and release of neuropeptides,"- ~10,000 neuropeptides packed into dense core vesicles (NOT refilled locally)<br>- released from many sites on neuron, have many different release proteins and Ca2+ sensitivity",0,,
what are the key differences between the storage and release of small molecule NTs and neuropeptides?,#NAME?,0,,
what are the key difference between the termination of action of small molecule NTs and neuropeptides?,#NAME?,0,,
describe the action of neuropeptides,"- mostly act on GPCRs<br><span style=""background-color: rgb(170, 0, 127);"">- very high affinity for their receptor (in nM range)</span><br>- act at auto, post or extra-synaptic receptors<br>- some peptides act at multiple receptors, some receptors have multiple peptide agonists",0,,
what are the key differences between the action of small molecule NTs and neuropeptides?,#NAME?,0,,
what are the two major classes of pain relieving drugs?,"1. opioids (morphine, codeine, oxycodone)<br>2. opioid-sparing drugs --&gt; to be used in combination w/ opioids (NSAIDs etc)",0,,
describe the three subtypes of opioid receptors and some of their functions,"1. µ - strong analgesia, constipation, nausea, respiratory depression, tolerance &amp; dependence (nearly all clinical opioids target µOR)<br>2. δ - spinal analgesia, convulsions?, cardiac complications<br>3. κ - moderate analgesia, hallucinations, diuersis",0,,
describe opioid action at the spinal cord,"nociceptors on primary afferent neurons fire after noxious stimuli and synapse in the dorsal horn of spinal cord.<br>two types of sensory fibres/primary afferent neurons --&gt; C fibres and Aδ fibres<br>C fibres are non-myelinated and do slow, throbbing pain. Most opioids act on C fibres]<br>Aδ fibres are lightly-myelinated and do immediate pain.",0,,
describe the physiological consequence of opioid agonism on µORs. refer to receptor location and structure.,µORs are located pre and post synapse.<br>pre synapse --&gt; µORs inhibit Cavs (β𝛾) and adenylyl cyclase (⍺). inhibition of N-type Cavs inhibits NT release and reduces synaptic potentials<br>post synapse --&gt; µORs open GIRK (K+) channels (β𝛾). opening GIRK blocks action potential and hyperpolarises cell membrane<br>Cav inhibition and GIRK opening β𝛾 subunit is main MOA for analgesia,0,,
describe different endogenous opioids and in which cells they act,"1. proenkephalin (nerve cells, adrenal). act on µ<br>2. prodynorphin (nerve cells). act on κ<br>3. ⍺-neoendorphin. activate µ<br>4. pro-opiomelanocortin (pituitary, brain-restricted)<br>A lot of these endogenous opioids/hormones are polypeptides",0,,
describe morphine related opioids and metabolites,- heroin &amp; codeine are prodrugs. they turn into morphine once in body.<br>- morphine has a hydroxyl substituent on phenyl ring (one not closest to nitrogen)<br>- heroin has an acetyl group instead of H (ie its an ester in that position). heroin is turned into active metabolite by an esterase.<br>- codeine has a methyl group instead of H (ie its a methyl ester in that position). codeine is turned into its active metabolite by CYP2D6.,i,,
what does the strength of a G protein signalling depend on?,1. intrinsic efficacy of agonist (not same as potency)<br>2. capacity of receptors to signal<br>3. capacity of cell to translate signal<br>4. tolerance modifies capacity of receptor and cell to signal,,,
how does buprenorphine act on µORs,"buprenorphine is a partial agonist. it binds very tightly to µOR (so other agonists and antagonists cant bind) and produces a weak G protein signal. weaker signal = lessened response (incl no high or respiatory depression), so is used for ppl who have opioid dependence (sorta like methadone)",,,
how/why are 5-HT and NA transporter inhibitors work for analgesia?,"- 5-HT<sub>2,3</sub> 'excites' inhibitory neurons synapsing onto ascending projection neurons &amp; reduces ascending pain transmission<br>- NA acts on ⍺2 (Gi/o) on projection neurons and reduces their excitability",,,
what is the role of prostaglandins (PGE2) in nociception? and what is the MOA of NSAIDs and give some examples,#REF!,,,
what is the difference between pain and nociception,nociception = activation of nociceptors&nbsp;<br>pain = entire physical and psychological experience,,,
what is inflammatory pain?,tissue injury and inflammation processes<br>often ongoing after nociceptor activity --&gt; maintains the pain,,,
what is neuropathic pain?,lesion or disease affecting the somatosensory system<br>causes:<br>1. trauma to peripheral nerves<br>2. central injury<br>3. disease<br>4. chemotherapy,,,
what are the symptoms of chronic pain?,1. spontaneous pain<br>2. allodynia (normally innocuous stimuli interpreted as painful)<br>3. hyperalgesia (painful stimuli more painful),,,
what are the current pharmacotherapies available for chronic pain?,"<div>- anticonvulsants: Gabapentin (blocks Cav)</div><div>- Cav channel blocker</div><div>- antidepressants: TCAs, SNRIs</div><div>- opioids</div><div>- Tramadol (partial opioid agonist + SNRI)</div><div>- topical drugs (capsaicin, anesthetics e.g. lignocaine)</div>",,,
what are some methods used to test chronic pain in animals?,<div>- induce neuropathic pain in animal e.g. sciatic nerve partial damage</div><div>- measure mechanical allodynia: pressure test on paw. measure # of pain responses</div><div>- measure cold allodynia: acetone drop on paw. measure # of pain responses</div><div>- measure mechanical or thermal hyperalgesia: heat or pressure test on paw. measure # of pain responses</div>,,,
how do drugs produce analgesia through targeting the pain pathways?,<div>- decrease ascending transmission (inhibit ascending pathway)</div><div>- activate descending pathway which then release NTs in spinal cord to stop ascending pathway</div>,,,
how is the physiology of the CNS different in those w/ neuropathic pain?,"<div>injury of peripheral afferents causes:</div><div>- hypotrophism (less nerve &amp; brain derived growth factors which support nerves)</div><div>- inflammatory immune response</div><div>- increased expression of diff VGCs such as Nav1.7, Cav, TRPV1</div><div>all this reduces the activation threshold and causes spontaneous pain</div><div><br></div><div>allodynia is caused by nerve sprouting &amp; non-noxious afferents activate pain ciruits</div>",,,
why do opioids not work well in neuropathic pain?,<div>- reduction in µORs&nbsp;</div><div>- µORs not expressed on non-noxious afferents</div><div>- still some reduction in activation of ascending pain pathway but not as effective as acute --&gt; also can't use opioids&nbsp;<i>chronically&nbsp;</i>for chronic pain</div>,,,
"how do Cav blockers, such as ziconotide, treat chronic pain?",<div>- ziconotide targets N-type Cav2.2 which are expressed on&nbsp;<i>all</i>&nbsp;afferents in CNS and PNS so needs to be administered intrathecally</div><div>- greater expression of Cav on afferents in chronic pain so better for targeting allodynia</div><div>- Ca causes NT release so blocking this decreases NT release&nbsp;</div>,,,
how do Gabapentin and Pregablin treat chronic pain?,<div>1. bind to ⍺2δ subunit of Cav2.2 and Cav2.1</div><div>2. decrease Cav expression in central terminal of afferents</div><div>3. less NT release and less excitation</div><div>4. reduces pain transmission</div><div><br></div><div>dosage is hard bc you're trafficking Cav not blocking. not effective for all chronic pain patients. abuse potential</div>,,,
how are TCAs and SNRIs used to treat chronic pain?,<div>- both drug classes block NA and 5HT transporters</div><div>- 5HT activates central descending systems and mood modulation of pain systems</div><div>- NA released from descending pathway to inhibit ascending pathway. NA acts on ⍺2 (Gi/o) on primary afferent terminals to reduce glutamate release and dorsal horn neurons to directly inhibit ascending pain pathway</div>,,,
how is capsaicin used to treat chronic pain?,"<div>- agonises TRPV1 LGICs predominantly expressed on C fibres and sense painful heat (above 40ºC)</div><div>- anti-nociceptive effect attributed to ""defunctionalisation"" of nociceptive fibres</div>",,,
what is the pathogenesis of headaches/migraines?,#NAME?,,,
describe the neurogenic inflammation theory of migraine&nbsp;,1. intracranial blood vessel constricts<br>2. trigeminal ganglion releases CGRP&nbsp;<br>3. TGN projects to trigeminal nucleus caudalis (brainstem)<br>4. TNC projects to ventroposterior medial thalamus&nbsp;<br>5. VMT projects to somatosensory and causes pain<br><br>severity of migraine is proportional to amount of CGRP released. CGRP release triggers CGRP synthesis,,,
what happens in the serotonin system during a migraine,- increase in 5HIAA (primary metbolite) during attack and decrease of 5HT,,,
what are the different types of 5HT receptors?,- 5-HT<sub>1A/B/D/E/F</sub> Gi/o coupled<br>- 5-HT<sub>2A/B/B</sub> Gs coupled,,,
describe 5-HT receptor expression in the trigeminovascular pathway,- trigeminal ganglion: 5-HT<sub>1B/1D</sub><br>- trigeminal nucleus caudalis (brainstem): 5-HT<sub>1B/1D/1F<br></sub>targeting these receptors reduces noxious signalling,,,
what are some drugs used to treat migraines in an acute manner (ie during an attack) and describe their MOA,"- NSAIDs --&gt; inhibit COX1/2 to decrease prostaglandin synthesis<br>- ergotamines --&gt; 5-HT<sub>1D</sub> partial agonist, blocks trigeminal nerve transmission<br>- triptans --&gt; 5-HT<sub>1B/1D/1F</sub> agonists, inhibit trigeminal nerve transmission centrally and peripherally and inhibits release of vasoactive peptides from trigeminal ganglia",,,
what drugs are used to treat migrane prophylactically (ie preventative)?,- β-adrenoreceptor agonists<br>- antidepressants (TCAs)<br>- 5-HT<sub>2</sub> antagonists<br>- anticonvulsants<br>- Cav blocker<br>- CGRP receptor monoclonal antibodies,,,
how do 5-HT<sub>2</sub>&nbsp;antagonists treat migraine prophylactically?,"e.g. pizotifen<br>- prevents 5-HT<sub>2</sub>&nbsp;mediated vasodilation (2º to NO) and consequent inflammation<br>- side effects: weight gain, antimuscarinic",,,
how do anticonvulsants treat migraine prophylactically?,"e.g. sodium valproate, gabapentin<br>- reduce cortical excitability by altering Cav activity<br>- decreases trigeminal neurotransmission<br>- teratogenic",,,
what is epilepsy &amp; what is the cause?,#NAME?,,,
what are the two main types of seizures. what are the specific types of seizures?,"two main:<br>1. focal seizures --&gt; begin in one area of brain<br>2. generalised seizures --&gt; occurs w/ all areas of brain being hyper excitable<br>specific types:<br>- tonic-clonic --&gt; stiff, jerking<br>- absence&nbsp; --&gt; blanking out<br>- myoclonic --&gt; jerking/twitching of muscles<br>- infantile --&gt; stiff &amp; movement of head &amp; limbs back and forth",,,
describe the symptoms and pathogenesis of Dravet syndrome,- severe encephalopathy w high seizure burden<br>- 80% of cases due to loss of function mutation in SCN1A gene (codes for ⍺ subunit of Nav1.1),,,
describe the symptoms and pathogenesis of Lennox-Gastaut syndrome,"- severe encephalopathy w high seizure burden (infantile, tonic, absence)<br>- causes: structural, genetic (D120N mutation --&gt; GABA<sub>A</sub> β3 subunit)",,,
describe the MOA of different antiseizure drugs,"1. modulating VGICs (inhibition &amp; enhancement of inactivation) e.g. lamotrigine<br>2. enhancing GABA-mediated inhibition e.g. benzodiazepines (diazepam PAM of GABA<sub>A</sub>)<br>3. interacing w/ synaptic release machinery e.g. levetiracetam binds synaptic vesicle glycoprotein<br>4. block ionotropic glutamate receptors e.g. perampanel blocks AMPA<br>5. combination of mechanisms e.g. cannabidiol, valproate",,,
describe preclinical models of epilepsy,"- screening against conventional epilepsy drug targets (5HT, GABAA)<br>- diff models used for screening: zebrafish &amp; rodents --&gt; good phenotypic relevance but very low human/patient relevance<br>- KO or KI of SCN1A to test Dravet",,,
describe the neural circuitry that regulates mood,"1. frontal cortex (FC) and hippocampus (HC) involved in cognition<br>2. nucleus accumbens (NAc) and amygdala (Amy) involved in emotion (NAc --&gt; rewarding, Amy --&gt; aversive)<br>3. hypothalamus (Hyp) anc monoamine brainstem nuclei (DR, LC) involved in vegetative symptoms e.g. appetite, energy",,,
describe the monoamine hypothesis of depression,- hypoNA/hypo5-HT state leads to receptor hyperresponsiveness<br>- SO antidepressants lead to ⇑ NA and ⇑ 5-HT<br>- AND down-regulating receptors to normal levels accounts for slow action of drugs,,,
describe the neuroendocrine hypothesis of depression,#NAME?,,,
describe the neurotrophic/neuroplasticity hypothesis of depression,stress &amp; depression associated w:<br>- neuronal loss in pFC and Hyp (has been seen on imaging)<br>- ⇓ BDNF &amp; TrKB receptors<br>- ⇓ neurogenesis<br>- maybe a genetic polymorphism in BDNF which predicts chronicity,,,
describe the current drug classes used to treat depression and give an example,- TCAs e.g. amitryptaline<br>- SSRIs e.g. fluoxetine<br>- SNRIs e.g. venlafaxine<br>- MAO<sub>A</sub> and MOA<sub>B</sub> inhibitors e.g. phenelzine<br>also tetracyclics and NRIs,,,
describe the MOA of SSRIs/SNRIs&nbsp;,"- block presynaptic 5-HT and NA transporters<br>- causes ⇑ [5-HT, NA]",,,
describe the MOA of TCAs w reference to a hypothesis of depression,"- block presynaptic 5-HT and NA transporters<br>- causes ⇑ [5-HT, NA]<br>- monoamine hypothesis states brain is in hypo5HT/hypoNA state, so increasing 5HT and NA rectifies this<br>- TCAs also block mAChR, 5HTR, ⍺-adrenoreceptors ∴⇑ side effects",,,
describe the MOA of MAO inhibitors&nbsp;,- inhibit breakdown of 5HT and NA<br>- increases cytoplasmic conc of monoamines<br>- increases leakage of monoamines into synapse,,,
describe the MOA of tetracyclic antidepressants,- block ⍺2 adrenoceptors<br>- causes increase 5HT and NA release,,,
describe the MOA of St John's Wart,"- block 5HT, NA, DA, GABA and glutamate reuptake by reducing Na<sup>+</sup> gradient",,,
compare the different side effects of different drug classes used to treat depression,"- TCAs have the most antimuscarinic effects (eg blurred vision, dry mouth) and cardiovascular (eg arrythmias)<br>- SSRIs have most gastrointestinal side effects (eg nausea) and CNS (eg dizziness)<br>- MAO-I's have cheese reaction (if you eat food w tryamine eg cheese it can be fatal)",,,
describe how antidepressants treat depression w reference to the monoamine hypothesis,- down-regulate postsynaptic NA (β-adrenoceptors) and/or 5-HT2 recpetors (Gs)<br>- increase activity/sensitivity of postsynaptic 5-HT1 (Gi/o) receptors in hippocampus<br>- desensitisation of presynaptic ⍺2 adrenoceptors (Gi/o) and 5-HT1 receptors which control 5HT and NA release --&gt; facilitates monoamine release<br>Net effect of chronic treatment is an enhancement of monoaminergic function&nbsp;,,,
describe how antidepressants treat depression w reference to the neurotrophic/neuroplasticity hypothesis&nbsp;,"- antidepressants enhance BDNF signalling, TrKB receptors and neurogenesis<br>--&gt; BDNF stimulates SERT transcription in raphe nuclei, 5HT receptor activation stimulates BDNF expression, thus ⇑ 5HT synthesis, release and cell function this may work to restore network function and in turn mood<br>- 5HT and NA promote neurogenesis by 5-HT<sub>1A</sub>, 5-HT<sub>2B</sub> and β-adrenoceptor stimulation and ⍺2-adrenoceptor blockade",,,
describe how antidepressants treat depression w reference to the neuroendocrine hypothesis,"- antidepressants are associated w glucocorticoid receptor (GR) phosphorylation via PKA, which ⇑ inhibition of GR to promote neurogenesis in Hipp<br>- hippocampal neurogenesis is necessary for restoration of HPA axis (ie to inhibit stress response)",,,
what is drug addiction?,"""a state where drug use continues in spite of serious potential or actual harm to the user or others""<br>""addiction is a brain disorder that results from a mix of genetic, neural, environmental and social causes""",,,
describe the role of genetics in addiction w reference to impulsivity,- alcoholism is strongest in terms of genetics<br>- highly impulsive (HI) humans have a high risk of drug abuse&nbsp;<br>- HI humans have different cortical structures and dopamine receptor expression,,,
describe how chronic drug uses effects neuroplasticity with reference to chronic opioid use,"neuroplasticity effected by:<br>1. tolerance --&gt; ⇓ response to same dose, can be due to changed receptor response<br>2. counter-adaptations --&gt; attempts to compensate for ongoing drug effects on cells, causes withdrawal and craving<br><br>with chronic opioid use, AC signalling becomes hypertrophied (up-regulated) which causes ⇑ cAMP and ⇑ excitation",,,
describe the important sites of opioid action in the brain,"- VTA --&gt; NAc is the reward pathway. opioids stimulate µORs on dopamine neurons in this pathway to cause euphoria<br>- medulla --&gt; respiratory depression, depression, blood pressure, arousal, nausea",,,
"describe how µOR antagonists are used to treat opioid addiction, describe the clinical effects and give an example",naltrexone<br>- occupies receptor and prevents binding&nbsp;<br>- need to detox before use<br>- poor compliance<br>- high relapse rate,,,
"describe how µOR agonists are used to treat opioid addiction, describe the clinical effects and give an example",methadone<br>- agonist w/ long half life ~22h --&gt; good for dosing<br>- stops withdrawal and craving w/o intoxication at correct dose<br>- overdose possible,,,
"describe how µOR partial agonists are used to treat opioid addiction, describe the clinical effects and give an example","buprenorphine&nbsp;<br>- partial agonist, prevents full agonists from activating receptor&nbsp;<br>- reduces craving<br>- prevents withdrawal&nbsp;<br>- less overdose risk than methadone",,,
describe the MOA of alcohol,- enhance GABAergic and glycinergic synaptic transmission --&gt; ⇑ inhibition<br>- inhibition Cav<br>- activation Kav<br>- inhibition of GABA receptor function<br>- inhibition of adenosine transport,,,
describe some of the treatments used in alcohol addiction,#NAME?,,,
describe how making alcohol unpleasant treats alcohol addiction. give an example of the drug and its MOA,"disulfiram<br>- inhibits aldehyde dehydrogenase<br>- causes flush, palpitations, nausea if you drink alcohol<br>- can't be used to treat cravings but can be used to treat cue-induced drug-seeking",,,
describe how acamprosate is used to treat alcohol addiction,- may act via inhibition of NMDA receptor (may alter plasticity)<br>- may alter GABA and glutmate synaptic transmission<br>-similar efficacy to naltrexone&nbsp;,,,
describe how topiramate is used to treat alcohol addiction,"- antiepileptic<br>- may alter phosphorylation of Nav, Cav, GABA &amp; glutamate channels<br>- may ⇑ GABA and ⇓glutamate synaptic transmission<br>- may have better treatment outcomes in ppl w kainate polymorphisms<br>- significant reduction&nbsp; in drinking but variable results",,,
what is the difference between sedatation and hypnosis,"sedation = ⇓ excitement, vigilance and physiological arousal to induce relaxation, possibly sleepy<br>hypnosis = ability to induce drowsiness and sleep&nbsp;",,,
describe the MOA of benzodiazepines,"- PAM of GABA<sub>A</sub>. binds between ⍺ and 𝛾 subunits (GABA<sub>A</sub> is a pentamer, on postsynaptic neuron)<br>- ⇑ GABA's&nbsp;affinity for receptor and as a result ⇑ # of channel openings<br>- causes Cl- influx in post-synaptic neuron causes ⇑ hyperpolarisation and ⇓ in excitability",,,
describe the MOA of barbiturates,- PAM of GABAA<br>- agonist at very high doses<br>- ⇑ length of channel opening,,,
describe how the type ⍺ subunit of a GABA<sub>A </sub>receptor determines the effect of a benzodiazepine,"⍺1 --&gt; sedative/hypnotic, anticonvulsant&nbsp;<br>⍺2 and ⍺3 --&gt; anxiolytic&nbsp;<br>⍺3 and ⍺3 --&gt; muscle relaxing",,,
describe the MOA of Z-drugs,"- not benzodiazepines because they lack benzodiazepine structure but they act at benzo site on GABAA<br>- show some preference for ⍺1 (sedative, hypnotic)<br>- may produce bizarre sleep behaviours",,,
describe the MOA of antihistamine use in sedation,#NAME?,,,
describe the MOA of melatonin use in sedation,- endogenous melatonin is synthesised in pineal gland<br>- melatonin is an agonist at MT1 and MT2 receptors (both Gi/o coupled GPCRs)<br>- MT1 --&gt; activation promotes sleep onset<br>- MT2 --&gt; activation shifts circadian timing<br>,,,
identify the NTs that are present in the ARAS (ascending reticular activation system) and the NTs that are sleep promoting,"ARAS = wakefulness promoting --&gt; NA, 5HT, ACh, dopamine, histamine<br>sleep promoting --&gt; GABA, adenosine, melatonin",,,
what are some problems associated with benzodiazepine usage?,"- shouldn't be used for &gt;1 month<br>- when stopping, udose needs to be tapered down<br>- large dependence liability<br>- strange sleep behaviours<br>- amnesia<br>- combination with other sedatives (eg alcohol) can be v dangerous",,,
describe the advantages and disadvantages of using benzodiazepines to treat anxiety,"recall: ⍺2 and ⍺3 subunits of GABAA promote anxiolytic<br>alprazolam and clonazepam used bc they show preference for ⍺2<br>advantage --&gt; rapid onset ∴ good for acute treatment<br>disadvantage --&gt; dependence potential, drowsiness",,,
what is anxiety and what brain regions does it involve,"""state of preparation for danger (eg ⇑ arousal) but no immediate danger""<br>- amygdala is up-regulated in fear disorders&nbsp;<br>- anxiety thought to be result of problems w synaptic plasticity in Amy circuits",,,
what are the current treatments for anxiety and briefly describe their MOA,- cognitive behavioural therapy<br>- benzodiazepines --&gt; GABAA PAM<br>- SSRIs<br>- SNRIs<br>- TCAs: prevent NA and 5HT reuptake<br>- pregabalin --&gt; GABA analogue that actions on ⍺2δ subtype of Cav to ⇑ GABA levels<br>- buspirone --&gt; partial 5HT1A (Gi/o) agonist. moderate efficacy,,,
what is schizophrenia?,"- a disorder of higher cognitive functioning caused by abnormalities in the brain (structural - white matter, ventricles, neurochemical - NTs, receptors)<br>- neurodevelopmental disorder&nbsp;<i>not&nbsp;</i>neurodegenerative<br>cause:<br>- genetic?<br>- pre/perinatal factors<br>- drug use&nbsp;<br>- stress from major life events",,,
describe the general MOA of antipsychotics,- all are D2 dopamine receptor (Gi) antagonists&nbsp;<br>- linear correlation between therapeutic efficacy and affinity for D2,,,
describe the dopamine hypothesis of schizophrenia,"dopaminergic dysfunction is what causes schizophrenia<br>1. ⇑ DA levels, synthesis and release in NAc, Hipp<br>2. ⇓ other NTs (eg GABA, glutmate) lead to DA dysregulation<br>3. D2 receptors are supersensitive --&gt; blockade ⇓ overactivity and alleviates psychosis",,,
what are the +ve and -ve symptoms of schizophrenia,positive:<br>- hallucinations<br>- delusions<br>- disorganised thought &amp; speech<br>negative:<br>- anhedonia<br>- aviolation/apathy (⇓ goal directed activities)<br>- flattened effect (reduced mood),,,
which neural pathways are responsible for the +ve and -ve symptoms of schizophrenia,"mesolimbic pathway: VTA --&gt; NAc, Amy, Hipp (dopaminergic). Hyperactivity causes positive symptoms<br>mesocortical pathway: VTA --&gt; FC (dopaminergic). Hyperactivity causes negative symptoms<br>nigrostriatal pathway: substantia nigra --&gt; dorsal striatum. Hyperactivity causes cognitive symptoms. Hyperactivity correlates w symptom severity",,,
what are the major classes of typical antipsychotics and give an example. what is their therapeutic effect?,1. phenothiazines eg chlorpromazine<br>2. butyrophenones eg haloperidol<br>3. thioxanthenes<br>these ameliorate the positive symptoms of schizophrenia but have little effect on negative and cognitive symptoms.,,,
what are the major classes of atypical antipsychotics and give an example. what is their therapeutic effect?,#NAME?,,,
describe the receptor actions of typical antipsychotics,"- potent D2 receptor agonists (80% occupany for therapeutic, slow dissociation)<br>- moderate affinity for ⍺-adrenoceptors and 5-HT2 receptors<br>- weak affinity for D1, D4, H1 and mACh",,,
describe the receptor actions of atypical antipsychotics,"- D2 antagonism w high affinity and/or selectivity, 60% occupancy at therapeutic doses<br>- high affinity for 5-HT2 (up to 90% occupancy)<br>- moderate affinity for ⍺-adrenoceptors and D3<br>- clozapine &amp; olanzapine have high affinity for D4",,,
compare and contrast the side effects of typical and atypical antipsychotics,typical:<br>- movement disorders (associated w D2)<br>- anticholinergic<br>- endocrine (weight gain associated w 5-HT2A)<br>atypical:<br>- agranulocytosis (clozapine)<br>- metabolic syndrome&nbsp;,,,
how do antipsychotics work in the short term &amp; long term,short term:<br>- blocking D2 autoreceptors ⇑ DA release<br>- blocking supersensitive D2 postsynaptic receptors ⇓ DA inhibition<br>long term:<br>- upregulation of presynaptic D2 ⇓ DA release<br>- blockade and upregulation of D2 restores homeostasis,,,
what is dementia,"""clinical syndrome associated w impaired memory and other intellectual functions which intefere with normal functioning and impair quality of life""<br>- progressive decline in mental function<br>- alzheimers disease accounts for 70% of dementia cases<br>- stroke and parkinsons each account for 15% of dementia cases",,,
describe the clinical features of alzheimers,"- changes in memory and cognition<br>- changes in spatial and temporal orientation<br>- difficulty forming new memories<br>- altered judgement<br>- +/- moodiness, depression, apathy",,,
identify &amp; describe the pathological features of alzheimers,"1. cerebral atrophy and ventricular enlargement (cavities that store CSF)<br>2. neuronal loss with gliosis (particularly cholinergic neurons, gliosis = scarring, occurs in Hipp, Amy, Cortex)<br>3. amyloid plaques (aggregation of amyloid proteins, most commonly amyloid-β peptide (39-44aa's long))<br>4. neurofibrillary tangles (abnormal bunches of filament in neurons, hyperphosphorylated tau protein (microtubule associated protein))",,,
describe the neurochemistry of alzheimers with reference to NTs,ACh - deficit in central cholinergic transmission:<br>- neuronal loss<br>- ⇓ choline acetyltransferase (synthesis)<br>- ⇓ AChE<br>- ⇓ choline uptake<br>Amines:<br>- ⇓ NA synthesis (from loss of cells in locus coeruleus)<br>- ⇓ 5HT synthesis (from loss of cells in raphe nuclei)<br>Glutamate:<br>- ⇓ glutamate transporters<br>- ⇑ excitotoxicity,,,
describe the genetics of alzheimers&nbsp;,"≥95% cases of alzheimers are sporadic (no genetic basis)<br>- amyloid precursor protein gene on chromosome 21<br>- presenelins (PS1 and PS2) genes on chromosome 1, 14 --&gt; may effect processing of APP (more Ab<sub>42 </sub>and Ab<sub>40</sub>, Ab<sub>42</sub> most commonly found in amyloid plaques)<br>- apolipoprotein (apoE) --&gt; determines age of onset. ε4 allele = onset in 80s, ε3 allele = onset in 90s",,,
identify different pharmacological treatments for alzheimers,"- cholinesterase inhibitors<br>- NMDA antagonist&nbsp;<br>- antidepressants<br>- β-secretase inhibitors (alters peptide cleavage to produce less Ab42) --&gt; experimental, low efficacy<br>- statins (prophylactic?) --&gt; cholesterol plays a role in APP synthesis<br>- Aducanumab --&gt; immunotherapy targets Aβ plaques in ppl w alzheimers to reduce their build up. serious side effects",,,
what happens when you react two glucose molecules? draw the curly arrow mechanism and name the product,"product is a disaccharide. similar to formation of a glycoside but the alcohol is just a substituent of glucose ring.<br><img src=""paste-2059be3cc5f6a22b67aa383941e8c3a3e138b03c.jpg"">",,,
what is an amino sugar?,"where an -OH group of a sugar is replaced by -NH2<br>this can be further functionalised by acetylation<br><img src=""paste-52a65aa48d810f05f6b20239573e4fb64de8562b.jpg"">",,,
"starch, glycogen and cellulose are all polymers of glucose. what makes them different from each other?","have different chain branching patterns<br>e.g. starch branches ⍺(1--&gt;6)&nbsp;<br><img src=""paste-b954b5a2cc52d1d169f23f48ee68464757aff286.jpg"">NB: in glycogen m=6-12<br>e.g. cellulose has β(1--&gt;4) linkage (no branching?). therefore humans cant get energy from cellulose bc we dont have the enzyme to hydrolyse this bond<br><img src=""paste-64d8336b05384063a14777d4d373579537e67d21.jpg"">",,,
describe how sugars determine blood type,#NAME?,,,
give some examples of sugars being used as drugs,"1. mannitol --&gt; osmotic agent, draws water into airways, useful in improving lung function in CF<br>2. penicillin --&gt; bacterias have sugars we dont have (NAM and NAG). penicillin inteferes w NAM branching",,,
why do sugars cause a sweet taste?,they contain the right # of H bond donors and H bond acceptors to interact w GPCRs to cause signalling cascade to brain that is interpreted as sweet tasting,,,
describe the role of cyclodextrins in food and give an example,cyclodextrin = cyclic polysaccharide which has a cavity that can bind molecules.&nbsp;<br>e.g. cholesterol free eggs:<br>1. whites &amp; yolks are separated<br>2. β-cyclodextrin is mixed w yolks to create a crystalline complex of β-cyclodextrin and cholesterol which is removed w centrifugion<br>3. add yolks and whites together and you have cholesterol free eggs,,,
describe the maillard reaction,"upon heating, amino acids react w reducing sugars<br>then form an imine then undergo amadori rearrangement (aldose --&gt; ketose)<br>then a sequence of rxns occur to form aromatic products that are responsible for the colour and taste of many diff foods",,,
what are lipids,#NAME?,,,
what are some functions of lipids,"1. storage --&gt; of energy<br>2. membranes --&gt; water insolubility makes lipids excellent barriers for delineating cells and organelles<br>3. messengers --&gt; steroids, prostaglandins and thromboxanes are all lipids",,,
"identify this molecule<br><img src=""paste-7ff7b6047ad558ea74ab7f3e1f378d42575a7b7e.jpg"">",prostaglandin E2 (PGE2) --&gt; inflammatory mediator,,,
"identify this molecule<br><img src=""paste-763b596b2c675110980534e9b31c784d93e900f0.jpg"">",thromboxane A2,,,
"identify this molecule<br><img src=""paste-d25642dce3a2a0a6d02f7705fbab79673adf5040.jpg"">",estrogen,,,
"identify this molecule<br><img src=""paste-527e69ea3bdac74d1ef9e22a5623a7f7e88087ed.jpg"">",cholesterol,,,
"identify this molecule<br><img src=""paste-3bcec106eba9e88c85975602eb8cd2bbf8359383.jpg"">",testosterone,,,
describe the nomenclature of unsaturated fatty acids,"C(C chain length):(#double bonds) cis/trans Δ<sup>(number of carbons away from COOH that double bond is)<br></sup>e.g. C18:1 cis Δ<sup>9<br></sup><img src=""paste-cc7a0ca5bba34753756c1576239a0000e28a10c6.jpg"">",,,
saturated fatty acids have _____ melting &amp; boiling points<br>unsaturated fatty acids have ______ melting &amp; boiling points,1. high (bc they have 'straight' carbon chains which ⇑ dispersion forces)<br>2. low,,,
describe the three types of complex lipids and give their general structure,"1. glycerophospholipids<br><img src=""paste-d262131386ce954e840cce16eeb6ec2cf7319865.jpg""><br>2. sphingolipids<br><img src=""paste-a4717144b14aac35a1d99bc9544a0906cb92f43c.jpg""><br>3. glycolipids<br><img src=""paste-425e5ff91afddc00f2e07f27abef36c936b4d3cc.jpg"">",,,
which alcohols are usually found in glycerophospholipids/phosphoglycerides,ethanolamine<br>choline<br>serine<br>inositol,,,
if the alcohol in a glycerophospholipid is ethanolamine or serine what is the lipid called?,a cephalin,,,
if the alcohol in a glycerophospholipid is choline what is the lipid called?,lecithin,,,
describe the structure of sphingolipids,"built around the poly-ol sphingosine rather than glycerol<br><img src=""paste-179a7f7cf30ee1538dfa71a7bd0d15710f09597e.jpg"">",,,
describe the function of sphingomyelin,"component of myelin sheath, which insulates nerves",,,
describe the structure of glycolipids,glycerol backbone. contain a sugar (can be mono or polysaccharide) but no phosphate<br>sphingoglycolipids have a sphingosine scaffold but contain a sugar&nbsp;,,,
describe the different structures than can arise from lipid self&nbsp;,planar bilayer sheet&nbsp;<br>micelle = spherical single layer<br>liposome = spherical bilayer,,,
describe how lipid structure influences phase transitions,phase transition temperature = T<sub>t<br></sub>- saturated FAs have ⇑T<sub>t&nbsp;</sub>bc ⇑VDW forces and more efficient packing<br>- unsaturated FAs (particularly cis) have ⇓T<sub>t&nbsp;</sub>bc chain kink disturbs packing and ⇓VDW forces,,,
describe the basic principles of differential scanning calorimetry and its usage in detecting changes in phase,"heat a sample &amp; a reference continually and measure ΔT between them<br>if both have same heat capacity, ΔT&nbsp;= 0<br>if a phase change occurs, ΔT&nbsp;&gt; 0<br>this means the heat capacity of the sample, which you measure?",,,
what is the core ring system of steroid hormones and describe the numbering system,"<img src=""paste-764ac16b152a3bf181df11802c1b1d491e3e1cc2.jpg"">",,,
describe the biosynthetic origin and function of cholesterol,"- most important 'steroid' in human body<br>- made in the liver<br>- starting material for testosterone, estrogen, bile salts etc<br>- essential component of cell membrane (up to 50% of plasma membrane)<br>- modulated function of membrane proteins e.g. Na+/K+ ATPase",,,
describe how cholesterol is transported throughout the body,#NAME?,,,
"describe the difference between VLDL, LDL and HDL",VLDL = very low density lipoprotein<br>- produced by liver<br>- triglyceride rich<br>- pro-atherogenic&nbsp;<br>LDL = low density lipoprotein<br>- derived from VLDL/IDL and are even more enriched in cholesterol<br>- carries the majority of cholesterol thats in circulation<br>HDL = high density lipoprotein<br>- transports cholesterol to liver where its excreted as bile<br>- transports cholesterol to organs where it is used to synthesise hormones,,,
describe cholesterol transport by VLDL and LDL,- carry cholesterol from liver to body<br>- LDL receptors on cells 'meet and greet' LDL<br>- high levels of LDL in blood linked to atherosclerosis (deposition of lipids and cholesterol into arterial wall),,,
what is the MOA of statins?,#NAME?,,,
what is the biosynthetic origin of sex hormones,#NAME?,,,
describe the biosynthetic origin and function of bile salts,- products of cholesterol metabolism<br>- stereochemistry bottom face of molecule is hydrophilic and the top face is hydrophobic<br>- natural surfactants --&gt; solubilise fats and assist in their absorption,,,
describe the biosynthetic origin and function of prostaglandins,- synthesised from arachidonic acid (oxidative ring closure catalysed by cyclooxygenase)<br>- key signalling molecules:<br>--&gt; stimulate uterine contractions (labour)<br>--&gt; relax muscles around blood vessels (lower blood pressure),,,
describe the biosynthetic origin and function of thromboxane,- synthesised from PGH2<br>- signalling molecule<br>- induces platelet aggregation --&gt; first step in blood clotting,,,
describe the biosynthetic origin and function of leukotrienes,#NAME?,,,
describe membrane asymmetry with reference to the different types of lipids,#NAME?,,,
how is membrane asymmetry maintained,"flippases, flopases&nbsp;<br>ATP dependent enzymes which translocate phospholipids",,,
"describe which direction flippase, floppase and scramblase translocate phospholipids",flippase = outer leaflet --&gt; inner leaf<br>floppase = inner leaflet --&gt; outer leaflet<br>scramblase = antiporter,,,
describe how membrane asymmetry across different organisms can be exploited in medicine,- bacteria have different lipid distribution &amp; asymmetry in their membranes<br>- PE and PG are major lipid components of bacterial membranes. PC is major one in animals<br>- can use this fact to target specific bacteria with new antimicrobials,,,
describe how membrane asymmetry can be exploited in medicine,#NAME?,,,
describe the timescale of lipid movement in a membrane,"rotational lipid rocking 10<sup>-9</sup>s<br>lateral movement 10<sup>-6</sup>s<br>transverse ""flip flop"" 10<sup>5</sup>s (seldom happens w/o an enzyme)",,,
how is lipid rocking measured and describe the basic principles&nbsp;,"- measured using fluoresence anisotropy (FA)<br>- based off principle that light emitted by a fluorophore has unequal intensities along diff axes of polarisation<br>- measure FA (which is r) by fluoresence intensity<br>- calculate rotational correlation time ɸ (ie time for a molecule to rotate by one radian)<br><img src=""paste-5779ed1d2f722a6250ad2c5bc77fe1099575fc05.jpg"">",,,
how is lipid lateral movement measured and describe the basic principles&nbsp;,"- measure using fluoresence recovery after photobleaching (FRAP)<br>- measures translational diffusion coefficients<br>- steps are bleach molecule of interest w fluoro tag (∴no more fluoresence), and time how bleached area recovers as non-bleached molecules diffuse in<br><img src=""paste-1f61a797b665ee88b41748037a20fe08994b525c.jpg""><br><img src=""paste-12bf73a79628cb644b318ee3f1e716ea91a00112.jpg"">",,,
how is lipid transverse movement measured and describe the basic principles&nbsp;,- measured using electron paramagnetic response spectroscopy<br>- determines kinetics of flip flop<br>- bascially add a nitroxide radical (paramagnetic) to some PCs in lipid bilayer --&gt; produces EPR signal<br>- add ascorbate which reduces nitroxide to be diagmagnetic --&gt; no EPR signal,,,
to form an ordered structure...,the energy of bond formation must overcome the randomising effect of kinetic energy&nbsp;,,,
what is the assembly of small molecules into organised structures governed by,"boltzmann distribution<br><img src=""paste-3f3a2ca6ecb80c781f6a11cf23847095efb6777b.jpg""><br>IMFs driving formation of structures must exceed thermal energy",,,
what determines whether a water-in-oil or oil-in-water emulsion will form?,"which is the major component of the mixture<br>if water --&gt; oil-in-water<br>if oil --&gt; water-in-oil (these are called&nbsp;<i>reverse micelles</i>)<br><img src=""paste-bc33520d3131c279252bfea81deee720edf02335.jpg"">",,,
how is soap prepared and how does it clean dirt?,"- saponification of fatty acids by treatment w NaOH gives 1 molecule of glycerol and 3 molecules of sodium sterate (which is a soap)<br>- sodium sterate can form micelles and encapsulate dirt<br><img src=""paste-a370bc96b779ad79c01c0bdd234a731ef06fc5a4.jpg"">",,,
describe how molecule structure determines structure shape,"- determined by critical packing parameter v/(a<sub>0</sub>l<sub>c</sub>), which relates volume of surfactant tail, area occupied by headgroup and length of surfactant tail<br>- if v/(a<sub>0</sub>l<sub>c</sub>) &lt; 1/3 --&gt; spherical micelle<br>- if 1/2 &lt; v/(a<sub>0</sub>l<sub>c</sub>) &lt; 1 --&gt; vesicle&nbsp;<br>- if v/(a<sub>0</sub>l<sub>c</sub>) = 1 --&gt; planar bilayer<br>- is v/(a<sub>0</sub>l<sub>c</sub>) &gt; 1 --&gt; reverse micelle",,,
describe the nature of gels,#NAME?,,,
describe the hydrophobic effect,"<img src=""paste-74aa102e5d85f9d546e9708befd9b218a4fec1c7.jpg"">",,,
describe π-π stacking,"when two π systems interact, they are not often face-to-face but staggered or offset --&gt; may be bc electrostatic replusion of e- clouds<br>∴its more of a π-σ attactraction<br><img src=""paste-7d8840e7e413e3cef80ae93066e87f1a604ec136.jpg""><br><img src=""paste-7399a92c5390e0dd2135c9c5b930646ab2e0547a.jpg"">",,,
describe the role of exciton theory π-π stacking and how this determines the colour of aromatic dyes,"- UV/Vis spec<br>- in a dimer, transition moments of monomers can be in phase or out of phase<br><img src=""paste-799109df024f8bc4694731d8854811d57d0b0f6e.jpg""><br>",,,
what is osmotic pressure,the amount of force applied to a solution that prevents solvent from moving across a semipermeable membrane.,,,
how is osmotic pressure measured&nbsp;,"- osmometer<br>- two chambers separated by semipermeable membrane<br>- each chamber has a capillary sticking up<br>- solvent flows to the solution side to produce hydrostatic pressure which opooses further flow<br>- π is calculated using difference of heights of liquid of the solutions<br><img src=""paste-625cf1663eef5679e49865a781a46f2c8e7475b2.jpg""><br>p=1x10<sup>3&nbsp;</sup>kg m<sup>-3</sup>",,,
how to calculate the osmotic pressure of an ideal solution,"<img src=""paste-33e98a163509f4886010a745b450044288371037.jpg""><br><img src=""paste-d561b89eb062b5290a42ea40640c0547a35b96fb.jpg"">",,,
what is an ideal solution,"<img src=""paste-adadaef11385cc1894620123294f187962099214.jpg""><br>enthalpy of mixing = 0",,,
what is chemical potential and how can it be used to understand osmotic pressure,"it is the gibbs free energy per mole of solute in solution (µ<sub>i</sub>)<br>water will flow from a high chemical potential (solvent) to low chemical potential (solution)<br>at equilibrium the chemical potential of a given component but be everywhere equal<br>in non-ideal conditions:<br><img src=""paste-5287c05be42de3eb98ab7b981757204aca6da5f1.jpg""><br><img src=""paste-402ce0d14430c0050e7c5c13499e16e5291585e6.jpg""><br>where gamma is just a correction factor called the activity coefficient (no units - is there so only the molecules contributing to chemical potential are contributing to ther eqn)",,,
describe the donnan effect,"the uneven distribution of ions across a cell membrane is due to the large amounts of impermable anionic macromolecules(mostly proteins) and organic phosphates in the cytoplasm<br>more K+ inside cell, more Cl- outside cell",,,
why must Na+ be continuously pumped out of cells?,⇓ # of particles in the cell<br>hence ⇓ osmotic pressure<br>prevents cell from swelling and possibly bursting,,,
describe the transport of ions by Na+/K+ ATPase,efflux of 3Na+ and influc of 2K+ per 1 hydrolysis of ATP<br>(active transport),,,
what is the nernst equation and what does it describe,"measures membrane potential V<sub>m</sub> (electrical potential difference across a membrane)<br><img src=""paste-ba9640635f9b3463d922a1669fe9438d9502613e.jpg"">",,,
how can you determine whether the dsitribution of ions across a membrane is at equilibrium,"eq when V<sub>m</sub><sup>exp</sup> ≈ V<sub>m</sub><br>if V<sub>m</sub><sup>exp</sup> &gt;&gt; V<sub>m</sub>, or V<sub>mexp</sub> &lt;&lt; Vm then the ions distribution is far from eq and ions must actively be being transported/pumped across the membrane",,,
what is the difference between equilibrium and steady state,"if membrane potential is constant, this means no&nbsp;<u>net</u>&nbsp;current flowing across membrane and flux of cations and anions cancel out<br>ɸ<sub>K+</sub>+ ɸ<sub>Na+</sub>+ ɸ<sub>Cl-&nbsp;</sub>= 0<br>this is the steady state approximation<br>diff from eq as steady state is maintained by expenditure of energy (ATP), cell goes eq when it dies",,,
"rank the ability of anions, cations and nonelectrolytes to cross the cell membrane with reference to their permeability coefficients","cations &lt; anions &lt; nonelectrolytes(uncharged, polar)<br>cations have low permeability coefficient P<sub>d&nbsp;</sub><br>nonelectrolytes have higher P<sub>d</sub><br>anions in between",,,
what is the equation for born energy and what does it describe?,"- describes the electrostatic energy necessary to transfer an ion from water into the membrane<br><img src=""paste-e4186c86dc423e83e824bad35f9453cdf64058b3.jpg""><br>multiply by avogadros number to get answer for one mole of ions",,,
describe the principles of noise analysis and what it measures,"- measures the current across the cell membrane as a function of time<br>- speed of current fluctuations is measures as the autocorrelation function G(τ)<br>- long τc --&gt; channels are opening and closing slowly<br>- short τc --&gt; channels are opening and closing quickly<br><img src=""paste-fcdcd01b719bf0940da90d385085d5d5f5b94018.jpg"">",,,
describe the principles of patch clamp and what it measures,- measures the flow of current across a membrane<br>1. suck a small area of membrane into a pipette (3-4nm across)<br>2. hope membrane patch has a channel and doesn't burst<br>3. measure fluctuations in current as a function of time and applied voltage<br>- 1pA measurable current,,,
describe how is the Na+ gradient across a membrane a store of energy,"ΔG = -50kJ mol-1 (ATP --&gt; ADP + Pi)<br>ΔG = +36kJ mol-1 (for movement of Na+ and K+ by ATPase)<br>there's 14kJmol of energy from ATP hydrolysis which is released as heat --&gt; if ATP hydrolysis occured w/o membrane no work would be done (all would be released as heat)<br>e.g.<br>Na+ gradient facilitates glucose reabsorption absorbtion (glucose reabs by itself is unfavourable, but Na+ transport makes it so Δµ<sub>Na+</sub> + Δµ<sub>G</sub> &lt; 0)",,,
